Anatara Lifesciences Embarks on Stage 2 of GaRP Trial for Treatment of Irritable Bowel Syndrome

Small CapsJun 10 19:20 ET

Anatara Lifesciences Raises AU$1 Million via Shares Placement; Shares Decline 6%

MT NewswiresApr 30 23:25 ET

Anatara Lifesciences Opens GaRP Therapy Trial Extension to Treat Irritable Bowel Syndrome

Small CapsApr 8 22:59 ET

Anatara Lifesciences Begins Recruitment for Irritable Bowel Syndrome Stage Two Trial

MT NewswiresApr 8 22:42 ET

Anatara Lifesciences Raised Nealy AU$960,000 Via Entitlement Offer

MT NewswiresDec 8, 2023 03:17 ET

Anatara Lifesciences to Proceed to Stage II of IBS Drug Trial

MT NewswiresSep 28, 2023 06:57 ET